← All Aptargroup, INC filings

Aptargroup, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
ATR
Aptargroup, INC
10-K: AptarGroup Reports 5% Sales Growth, Strategic Acquisitions in 2025
AptarGroup, a global leader in dispensing and drug delivery solutions, reported a 5% increase in net sales to $3.78 billion for fiscal year 2025, driven by strong Pharma and Closures segment performance and strategic acquisitions.
NYSE
ATR
Aptargroup, INC
10-K: AptarGroup Reports 3% Sales Growth in 2024, Driven by Pharma and Strategic Acquisitions
AptarGroup's 2024 annual report reveals a 3% increase in both reported and core sales, reaching $3.58 billion, fueled by favorable product mix and volume growth.
NYSE
ATR
Aptargroup, INC
10-K: AptarGroup, Inc. Files 10-K Report, Details 5% Sales Growth and Strategic Realignment
AptarGroup, Inc. reports a 5% increase in net sales and a strategic realignment of its business segments in its annual 10-K filing.